Skip to content

Spinal Motor Evoked Potentials in Brain Surgery

Spinal Motor Evoked Potentials During Neurosurgical Procedures Within the Central Region

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02402075
Enrollment
40
Registered
2015-03-30
Start date
2014-01-31
Completion date
2015-12-31
Last updated
2015-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumor, Glioma

Keywords

muscle motor evoked potentials, spinal motor evoked potentials, D-wave, brain tumor surgery, intraoperative neuromonitoring

Brief summary

During neurosurgical resection of brain tumors within brain areas for motor control, it is important to monitor motor function. For this muscle motor evoked potentials are used. Those are elicited by transcranial and direct cortical stimulation. Motor responses are recorded from muscles. In neurosurgical procedures for spinal cord tumors, the same methods are used, but additionally motor activity is recorded from the spinal cord. This is called spinal motor evoked potentials. It is known that the relation between spinal and muscle motor evoked potentials helps to extent the resection of spinal cord tumors. This study implements the spinal motor evoked potential into brain tumor surgery and analyses the relationship between spinal and muscle motor evoked potentials. With this, detection of injury to the brain area for motor control might be discovered earlier and thus tumor resection can be performed safely.

Interventions

None listed

Sponsors

Johann Wolfgang Goethe University Hospital
CollaboratorOTHER
Heinrich-Heine University, Duesseldorf
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \> 18 years * tumor location adjacent to the motor cortex and corticospinal tract

Exclusion criteria

* minor * neurological degenerative diseases * neurological immunological diseases * drug abuse * implanted medical devices such as cardiac pacemaker * spine deformation

Design outcomes

Primary

MeasureTime frameDescription
D-wave measurement24 hoursnumeric assessment, amplitude and latency of D-wave
Clinical motor status according to the MRC scheme6 monthsclinical motor status according to the MRC scheme

Countries

Germany

Contacts

Primary ContactAndrea Szelenyi, MD PhD
andrea.szelenyi@uni-duesseldorf.de+492118117646

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026